Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer

【Author】

Chunfa Chen;Yuling Zhang;Ziyi Huang;Jundong Wu;Wenhe Huang;Guojun Zhang;Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Shantou University Medical College;Department of Information, Cancer Hospital of Shantou University Medical College;The Breast Center, Cancer Hospital of Shantou University Medical College;Cancer Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University;Changjiang Scholar's Laboratory, Cancer Hospital of Shantou University Medical College;

【Institution】

Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Shantou University Medical College;Department of Information, Cancer Hospital of Shantou University Medical College;The Breast Center, Cancer Hospital of Shantou University Medical College;Cancer Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University;Changjiang Scholar's Laboratory, Cancer Hospital of Shantou University Medical College;

【Abstract】

Objective: The purpose of this study was to explore the optimal cutoffs of the three parameters of Ki67 during NAC for predicting patient prognosis and investigate whether the optimal cutoffs of the Ki67 values were associated with relapse-free survival(RFS) or breast cancer-specific survival(BCSS).Methods: A total of 92 patients with locally advanced breast cancer(LABC), who had residual disease after NAC were retrospectively investigated.The optimal cutoff values of the Ki67 parameters were assessed by the online algorithm Cutoff Finder.Kaplan-Meier analysis, the log-rank test and Cox regression analysis were carried out to analyze survival.Results: The optimal cutoff values for the postsurgical Ki67 level and the decrease in the Ki67 level during NAC were defined as 25% and 12.5%, respectively.According to the univariate survival analysis, a higher Ki67 level in residual disease was associated with poor RFS(P = 0.004) and BCSS(P = 0.014).In addition, a Ki67 expression decrease > 12.5% during NAC was related to favorable RFS(P = 0.007), but was not related to BCSS(P = 0.452).Cox regression analysis showed that the Ki67 expression decrease(> 12.5% vs.≤ 12.5%) and histological grade(grade 3 vs.grade 1-2) were the independent factors associated with RFS(P =0.020 and P = 0.023, respectively), with HR values of 0.353(95% CI: 0.147-0.850) and 3.422(95% CI: 1.188-9.858), respectively.Conclusions: The Ki67 decrease was one of the independent factors associated with RFS in LABC patients with residual disease after receiving NAC.

【Keywords】

Ki67;;locally advanced breast cancer;;neoadjuvant chemotherapy;;prognosis;;residual disease

References

To explore the background and basis of the node document

Springer Journals Database

Total: 15 articles

  • [1] Rinat Yerushalmi;;Ryan Woods;;Peter M Ravdin;;Malcolm M Hayes;;Karen A Gelmon, Ki67 in breast cancer: prognostic and predictive potential, Lancet Oncology,
  • [2] T. Tanei;;A. Shimomura;;K. Shimazu;;T. Nakayama;;S.J. Kim;;T. Iwamoto;;Y. Tamaki;;S. Noguchi, Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer, European Journal of Surgical Oncology,
  • [3] Andreas Schneeweiss;;Julia Katretchko;;Hans-Peter Sinn;;Kristina Unnebrink;;Christian Rudlowski;;Matthias Geberth;;Frank Beldermann;;Gunther Bastert;;Hans-Joachim Strittmatter, Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy, Anti-Cancer Drugs,
  • [4] Yoshinari Ogawa;;Takuya Moriya;;Yasuyuki Kato;;Mitsue Oguma;;Katsumi Ikeda;;Tsutomu Takashima;;Bunzo Nakata;;Tetsuro Ishikawa;;Kosei Hirakawa, Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: Analysis for a cut-off point as the predictor for endocrine therapy, Breast Cancer,

More>>

Similar documents

Documents that have the similar content to the node document

Springer Journals Database

Total: 21 articles

  • [1] S.Issaragrisil, THE ROLE OF ETOPOSIDE (VP-16) IN PREPARATORY REGIMENS FOR PATIENTS WITH LEUKEMIA UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION, Chinese Medical Journal, 1994 (10)
  • [2] End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B, World Journal of Gastroenterology, 2004 (24)
  • [3] Chantal L Koelewijn;Matthijs P Schwartz;Melvin Samsom;Bas Oldenburg;, C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease, World Journal of Gastroenterology, 2008 (01)
  • [4] Shigeo Koido;Toshifumi Ohkusa;Hiroaki Saito;Tetsuji Yokoyama;Tomoyoshi Shibuya;Naoto Sakamoto;Kan Uchiyama;Hiroshi Arakawa;Taro Osada;Akihito Nagahara;Sumio Watanabe;Hisao Tajiri;, Seasonal variations in the onset of ulcerative colitis in Japan, World Journal of Gastroenterology, 2013 (47)

More>>